XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

14. FAIR VALUE OF FINANCIAL INSTRUMENTS

As of June 30, 2020 and December 31, 2019, the following financial assets and liabilities are measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 

 

 

June 30,

 

 

December 31,

 

Level 3 Assets

 

2020

 

 

2019

 

Compound embedded option

 

$

8,605

 

 

$

 

 

 

 

 

 

 

 

 

 

Level 3 Liabilities

 

 

 

 

 

 

 

 

Contingent consideration payable, current

 

$

36,395

 

 

$

8,614

 

Contingent consideration payable, long term

 

 

9,117

 

 

 

379

 

Contingent put option

 

 

14,125

 

 

 

7,100

 

Warrant options

 

 

46,978

 

 

 

16,878

 

Total

 

$

98,010

 

 

$

32,971

 

 

The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for the six months ended June 30, 2020 and June 30, 2019:

 

 

Level 3

 

 

 

 

 

 

Assets

 

 

Liabilities

 

 

 

 

 

 

Compound

Embedded

Option

 

 

Contingent

Consideration

Current(1)

 

 

Contingent

Consideration

Long Term(2)

 

 

Contingent

Put Option

 

 

Warrant

Options

 

 

Total

 

Balance—at December 31, 2018

$

 

 

$

2,754

 

 

$

 

 

$

 

 

$

12,818

 

 

$

15,572

 

Acquisitions

 

 

 

 

31

 

 

 

 

 

 

 

 

 

 

 

 

31

 

Changes in fair value included in earnings

 

 

 

 

(926

)

 

 

 

 

 

 

 

 

1,549

 

 

 

623

 

Balance—at June 30, 2019

$

 

 

$

1,859

 

 

$

 

 

$

 

 

$

14,367

 

 

$

16,226

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance—at December 31, 2019

$

 

 

$

8,614

 

 

$

379

 

 

$

7,100

 

 

$

16,878

 

 

$

32,971

 

   Payment of contingent consideration

   payable

 

 

 

 

(12,250

)

 

 

 

 

 

 

 

 

 

 

 

(12,250

)

    Foreign currency translation of contingent

   consideration payment

 

 

 

 

(208

)

 

 

 

 

 

 

 

 

 

 

 

(208

)

   Acquisitions

 

 

 

 

 

34,451

 

 

 

10,543

 

 

 

 

 

 

 

 

 

 

 

44,994

 

   Series A-2 compound embedded option

 

9,361

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,361

)

   Issuance of warrant option

 

 

 

 

 

 

 

 

 

 

 

 

 

30,099

 

 

 

30,099

 

   Reclass of long term to short term contingent

   liabilities

 

 

 

 

180

 

 

 

(180

)

 

 

 

 

 

 

 

 

 

   Changes in fair value included in earnings

 

(756

)

 

 

5,608

 

 

 

(1,625

)

 

 

7,025

 

 

 

1

 

 

 

11,765

 

Balance—at June 30, 2020

$

8,605

 

 

$

36,395

 

 

$

9,117

 

 

$

14,125

 

 

$

46,978

 

 

$

98,010

 

 

(1)

Current portion of the contingent consideration is recorded in accounts payable and other accrued liabilities.

(2)

Long term portion of the contingent consideration is recorded in other non-current liabilities.

Quantitative Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3):

Contingent Consideration Payable—CTEH’s contingent consideration payable fair value was valued using a Monte Carlo simulation analysis in a risk-neutral framework with assumptions for volatility, risk-free rate and dividend yield. The fair values of the contingent consideration payables for the other acquisitions were calculated based on expected target achievement amounts, which are measured quarterly and then subsequently adjusted to actuals at the target measurement date.

The method used to price these liabilities is considered level 3 due to the subjective nature of the unobservable inputs used to determine the fair value. The input is the expected achievement of earnout thresholds.

Compound Embedded Option—The fair value of the compound embedded option associated with the issuance of the Convertible and Redeemable Series A-2 Preferred Stock was estimated using a “with-and-without” method. The “with-and-without” methodology involves valuing the whole instrument on an as-is basis and then valuing the instrument without the embedded derivative feature. The difference between the entire instrument with the embedded derivative feature compared to the instrument without the embedded derivative feature is the fair value of the derivative. The unobservable inputs are based on a 100% probability of an IPO event and IPO date. The considerable quantifiable inputs in the compound embedded option were: (i) the future value of the compound embedded option, (ii) the fair value of the Convertible and Redeemable Series A-2 Preferred Stock, (iii) the present value of the total instrument, as well as the present value of the compound embedded feature plus the fair value of the instrument, and (iv) the risk free, discount rates, conversion date and maximum conversion amounts.

Contingent Put Option—The fair value of the contingent put option associated with the issuance of the Redeemable Series A-1 Preferred Stock was estimated using a “with-and-without” method. The “with-and-without” methodology involves valuing the whole instrument on an as-is basis and then valuing the instrument without the individual embedded contingent put option. The difference between the entire instrument with the embedded contingent put option compared to the instrument without the embedded contingent put option is the fair value of the derivative, recorded as the contingent put option liability. The unobservable inputs are based on a 100% probability of an IPO event and IPO date. The considerable quantifiable inputs in the contingent put option liability were: (i) the future value of the put option, (ii) the fair value of the Redeemable Series A-1 Preferred Stock, (iii) the present value of the total instrument, as well as the present value of the contingent put option feature plus the fair value of the instrument, and (iv) the risk free and discount rates. The contingent put option was redeemed in July 2020 (Note 22).

Warrant Options—The fair value of the warrant option associated with the issuance of the Redeemable Series A-1 Preferred Stock was calculated based on the Black-Sholes pricing model using the following assumptions:

 

 

 

June 30,

 

 

 

2020

 

 

2019

 

Common stock value (per share)

 

$

31.60

 

 

$

26.90

 

Expected volatility

 

 

43.64

%

 

 

49.17

%

Risk-free interest rate

 

 

0.66

%

 

 

2.00

%

Expected life (years)

 

 

10

 

 

 

10

 

 

The fair value of the warrant option associated with the issuance of the Convertible and Redeemable Series A-2 Preferred Stock was calculated based on a Monte Carlo simulation analysis with assumptions for (i) stock price, (ii) volatility based on the median historical volatility of publicly listed comparable companies’ stock price returns, (iii) risk-free rates based on U.S. treasury yields and (iv) dividend yield.

The method used to price these liabilities is considered Level 3 due to the subjective nature of the unobservable inputs (common stock value and expected volatility) used to determine the fair value.